DNM1L and neurodegenerative disease: This article also summarizes the recent developments in phosphorylated Drp1, current status of Drp1 inhibitors, and how reduced Drp1 protects against excessive fragmentation of mitochondria in Alzheimer’s and other neurodegenerative diseases.